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aDept. of Pharm. Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205,
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The title compound, C21H25NO3 [systematic name: (1aR,4E,7aS,8E,10aS,10bR)-
8-(2-aminobenzylidene)-1a,5-dimethyl-2,3,6,7,7a,8,10a,10b-octahydrooxireno
[20,30:9,10]cyclodeca[1,2-b]furan-9(1aH)-one], was synthesized by the reaction of
parthenolide [systematic name (1aR,7aS,10aS,10bS,E)-1a,5-dimethyl-8-methyl-
ene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[20,30:9,10]cyclodeca[1,2-b]furan-
9(1aH)-one] with 2-iodoaniline via Heck reaction conditions. The molecule is
composed of fused ten-, five- (lactone), and three-membered (epoxide) rings.
The lactone ring shows a flattened envelope-type conformation (r.m.s. deviation
from planarity = 0.0477 A˚), and bears a 2-aminobenzylidene substituent that is
disordered over two conformations [occupancy factors 0.901 (4) and 0.099 (4)].
The ten-membered ring has an approximate chair–chair conformation. The
dihedral angle between the 2-aminobenzylidine moiety (major component) and
the lactone ring (mean plane) is 59.93 (7). There are no conventional hydrogen
bonds, but there are a number of weaker C—H  O-type interactions.
1. Chemical context
Sesquiterpene lactones (SLs) are a large family of natural
products that have been widely investigated for their anti-
cancer activity. Parthenolide (PTL), a naturally occurring
germacranolide SL (Minnaard et al., 1999) isolated from the
feverfew plant (Tanacetum parthenium) (Knight, 1995), has
unique biological properties and selectively targets leukemia
stem cells (LSC) compared to normal hematopoietic stem cells
(Guzman et al., 2005). PTL has been demonstrated to inhibit
the NFkB pathway in LSCs, and also increases reactive oxygen
species, and inhibits STAT3 (signal transduction and activa-
tion of transcription) (Mathema et al., 2012). Synthetic
analogues of SLs are also excellent sources of novel chemical
entities for drug discovery, and over the last decade have been
developed as efficacious anticancer drugs (Ghantous et al.,
2010). Previous work from our laboratory (Nasim & Crooks,
2008) reported the amino analogues of PTL as anti-leukemic
agents, and moreover a water-soluble analogue of PTL, di-
methylaminoparthenolide (DMAPT), has advanced into
clinical studies (Ghantous et al., 2010). Recently, Kempema et
al. (2015) have reported C1 to C10-modified PTL analogues as
anti-leukemic agents. Han et al. (2009) have also reported
Heck products of PTL as anti-cancer agents. In continuing
efforts from our group, Penthala et al. (2014a) reported Heck
products of PTL and Melampomagnolide B as anti-cancer
agents. Subsequently, Bommagani et al. (2015) reported the
crystal structure of (E)-13-(pyrimidin-5-yl)-parthenolide, an
ISSN 2056-9890
analog of PTL, which was found to have an E-configuration at
C-13. The useful biological properties of PTL and its analogs
directed our attention to design and synthesize novel bioactive
analogs. In order to obtain detailed information on the
structural conformation of the current molecule and to
determine the geometry of the exocyclic double bond, a
single-crystal X-ray structure determination has been carried
out.
2. Structural commentary
The title compound (Fig. 1) is built from the PTL substructure,
which contains a ten-membered carbocyclic ring (chair–chair
conformation) merged to a lactone ring, and an epoxide ring,
as previously reported (Castan˜eda-Acosta et al., 1993). The
lactone ring has a flattened envelope-type conformation,
wherein atoms C6 and C7 reside 0.093 (4) and 0.105 (4) A˚
above and below the mean plane through atoms C11, C12, O2,
and O3. The molecule also contains a 2-aminobenzylidene
group attached by an E-exocyclic C11 C13 olefinic bond.
The 2-aminobenzylidene ring is twisted out of the plane of the
furan ring, subtending a dihedral angle of 59.93 (7). All other
bond lengths and angles are largely unremarkable.
3. Supramolecular features
There are no conventional hydrogen bonds in the crystal
structure, although there are a number of weaker C—H  O-
type interactions (Table 1). The most striking packing feature
consists of 21 screw-related (1  x, 12 + y, z) stacking of
lactone groups parallel to the b axis (Fig. 2). The distance
between planes of adjacent lactone rings is therefore half the
b-axis length.
4. Database survey
A search of the November 2017 release (with three incre-
mental updates) of the Cambridge Structure Database
(Groom et al., 2016) for the PTL substructure gave 30 hits.
Three of these, PARTEN (Quick & Rogers, 1976),
PARTEN01 (Bartsch et al., 1983), and PARTEN02 (Long et
al., 2013) give the structure of PTL itself. One (EBOLOZ,
Jamal et al., 2014) is flagged in the CSD as a stereoisomer of
parthenolide, though from the context it appears to be
parthenolide with an incorrectly assigned absolute configura-
tion. The remaining 26 are substituted variants of PTL. Of
these, only six entries: HORZOF (Penthala et al., 2014b),
HUKLAB, HUKLEF (Han et al., 2009), QILGEZ (Penthala
et al., 2013), RUTPON (Bommagani et al., 2015), and
BEMHIN (El Bouakher et al., 2017) are substituted at the
exocyclic double bond.
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Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C5—H5  O3i 1.00 2.59 3.268 (3) 125
C7—H7  O3i 1.00 2.57 3.226 (3) 123
C15—H15A  O1ii 0.98 2.40 3.223 (3) 141
Symmetry codes: (i) xþ 1; y 12;z; (ii) x; yþ 12;z.
Figure 1
The molecular structure of the title compound with ellipsoids drawn at
the 50% probability level.
Figure 2
A packing plot showing the stacking of 21 screw-related adjacent lactone
groups. The stacking direction, shown by a dashed line, is parallel to the
crystallographic b axis. For emphasis, lactone-group atoms are depicted as
solid balls. For clarity, hydrogen atoms and minor disorder components
are omitted.
5. Synthesis and crystallization
Synthetic procedures: The title compound, containing the PTL
substructure, was synthesized by the previously reported
literature procedure (Han et al., 2009). In brief, parthenolide
(1 mmol), 2-iodoaniline (1.2 mmol), triethylamine (3.0 mmol)
and 5 mol% of palladium acetate were charged into di-
methylformamide (2 ml) at room temperature. The reactants
were stirred at 333–343 K for 24 h. After completion of the
reaction, water was added to the reaction mass at room
temperature, and the mixture was extracted into diethyl ether
(2  30 mL). The combined organic layers were dried over
anhydrous sodium sulfate, concentrated and purified by silica
gel column chromatography.
Crystallization: The title compound was recrystallized from
a mixture of hexane and acetone (9:1), which gave colorless
crystals upon slow evaporation of the solution at room
temperature over 24 h. Melting point 457–459 K. 1H NMR
(400 MHz, CDCl3d):  7.63 (s, 1H), 7.17 (d, J = 6.4 Hz, 2H),
6.78 (dd, J = 7.6 Hz, J = 18.4 Hz, 2H), 5.26 (d, J = 11.6 Hz, 1H),
3.97 (s, 2H), 3.92 (t, J = 7.6 Hz, J = 15.6 Hz, 1H), 2.87–2.83 (m,
2H), 2.42–2.38 (m, 1H), 2.20–2.08 (m, 4H), 2.08–1.96 (m, 1H),
1.74 (d, J = 18.0 Hz, 1H), 1.63 (s, 3H), 1.36–1.26 (m, 4H) ppm;
13C NMR (100 MHz, CDCl3d)  171.17, 145.47, 135.37, 133.98,
131.11, 130.06, 129.05, 124.82, 118.93, 118.25, 116.21, 83.33,
66.91, 61.85, 47.42, 41.54, 36.49, 29.76, 24.42, 17.62, 17.54 ppm;
(ESI): m/z C21H26NO3 [M + H] 340.28.
6. Refinement details
Crystal data, data collection and structure refinement details
are summarized in Table 2. H atoms were found in difference-
Fourier maps. Carbon-bound hydrogens were subsequently
placed at idealized positions with constrained distances of
0.98 A˚ (RCH3), 0.99 A˚ (R2CH2), 1.00 A˚ (R3CH) and 0.95 A˚
(Csp2H). Nitrogen-bound hydrogens on the major disorder
component were refined freely, while those on the minor
component were heavily restrained. Uiso(H) values were set to
either 1.2Ueq or 1.5Ueq (RCH3) of the attached atom.
To ensure satisfactory refinement of disordered groups in
the structure, a combination of constraints and restraints were
employed. The constraints (SHELXL commands EXYZ and
EADP) were used to fix parameters of superimposed or
partially overlapping fragments. Restraints (SHELXL
command SADI) were used to maintain the integrity of ill-
defined or disordered groups. Refinement progress was
checked using PLATON (Spek, 2009) and by an R-tensor
(Parkin, 2000).
The minor component of disorder of the amine was
apparent in a difference map. Given the small occupancy
factor (only about 10%), the geometry of the minor compo-
nent is approximate, and its hydrogen atoms were included
merely to achieve the correct atom count.
The conventionally calculated Flack parameter does not
convincingly indicate the proper assignment of absolute
configuration. An alternative formulation of the chirality
parameter using Parsons quotients (Parsons et al., 2013) [the
so-called ’z0 parameter = 0.07 (7)] as calculated by PLATON
(Spek, 2009) is much more definitive.
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Computing details 
Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT (Bruker, 2006); data reduction: SAINT (Bruker, 2006); 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2013 
(Sheldrick, 2015); molecular graphics: XP in SHELXTL (Sheldrick, 2008); software used to prepare material for 







a = 11.6136 (3) Å
b = 6.2403 (1) Å
c = 12.6875 (3) Å
β = 104.385 (1)°
V = 890.67 (3) Å3
Z = 2
F(000) = 364
Dx = 1.266 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 9958 reflections
θ = 3.9–68.2°
µ = 0.67 mm−1
T = 90 K
Block, colourless
0.16 × 0.12 × 0.08 mm
Data collection 
Bruker X8 Proteum 
diffractometer
Radiation source: fine-focus rotating anode
Detector resolution: 5.6 pixels mm-1
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Krause et al., 2015)
Tmin = 0.840, Tmax = 0.942
24004 measured reflections
2592 independent reflections
2559 reflections with I > 2σ(I)
Rint = 0.041













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: mixed
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.0449P)2 + 0.1894P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.18 e Å−3
Δρmin = −0.14 e Å−3
supporting information
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Absolute structure: Flack x determined using 
811 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 
2013), as calculated by PLATON (Spek, 2009).
Absolute structure parameter: 0.07 (7)
Special details 
Experimental. The crystal was mounted with polyisobutene oil on the tip of a fine glass fibre, fastened in a copper 
mounting pin with electrical solder. It was placed directly into the cold stream of a liquid nitrogen based cryostat, 
according to published methods (Hope, 1994; Parkin & Hope, 1998). 
Diffraction data were collected with the crystal at 90K, which is standard practice in this laboratory for the majority of 
flash-cooled crystals.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement progress was checked using Platon (Spek, 2009) and by an R-tensor (Parkin, 2000). The final 
model was further checked with the IUCr utility checkCIF.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq Occ. (<1)
O1 0.15259 (14) 0.2877 (3) −0.01598 (12) 0.0449 (5)
O2 0.37973 (12) 0.4845 (3) 0.01116 (10) 0.0310 (3)
O3 0.57392 (13) 0.4878 (3) 0.08619 (10) 0.0338 (3)
C1 0.0887 (2) 0.3088 (4) −0.34185 (17) 0.0352 (5)
H1 0.1376 0.1884 −0.3456 0.042*
C2 −0.0258 (2) 0.2614 (4) −0.31056 (19) 0.0398 (6)
H2A −0.0672 0.1415 −0.3555 0.048*
H2B −0.0781 0.3887 −0.3256 0.048*
C3 −0.0032 (2) 0.2016 (5) −0.18904 (19) 0.0408 (6)
H3A −0.0797 0.1974 −0.1680 0.049*
H3B 0.0331 0.0573 −0.1769 0.049*
C4 0.07850 (19) 0.3630 (4) −0.11934 (17) 0.0353 (5)
C5 0.20641 (18) 0.3246 (4) −0.10509 (17) 0.0328 (5)
H5 0.2251 0.1905 −0.1407 0.039*
C6 0.29816 (17) 0.4982 (4) −0.09641 (14) 0.0288 (4)
H6 0.2587 0.6418 −0.1064 0.035*
C7 0.37413 (16) 0.4677 (4) −0.18048 (14) 0.0262 (4)
H7 0.3626 0.3171 −0.2080 0.031*
C8 0.34284 (18) 0.6194 (4) −0.28030 (15) 0.0287 (5)
H8A 0.3081 0.7530 −0.2596 0.034*
H8B 0.4167 0.6578 −0.3014 0.034*
C9 0.25450 (18) 0.5184 (4) −0.37888 (14) 0.0314 (5)
H9A 0.2521 0.6076 −0.4439 0.038*
H9B 0.2840 0.3748 −0.3924 0.038*
C10 0.12982 (17) 0.4963 (4) −0.36473 (13) 0.0286 (4)
C11 0.49909 (17) 0.4865 (4) −0.11042 (13) 0.0255 (4)
C12 0.49328 (19) 0.4875 (4) 0.00462 (15) 0.0280 (4)
C13 0.60415 (17) 0.5038 (4) −0.13427 (14) 0.0282 (4)
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H13 0.6711 0.5207 −0.0742 0.034*
C14 0.0631 (2) 0.7032 (4) −0.37465 (19) 0.0395 (6)
H14A −0.0194 0.6752 −0.3727 0.059*
H14B 0.0644 0.7725 −0.4436 0.059*
H14C 0.1005 0.7976 −0.3141 0.059*
C15 0.0281 (2) 0.5807 (5) −0.1117 (2) 0.0436 (6)
H15A −0.0376 0.5705 −0.0762 0.065*
H15B −0.0013 0.6402 −0.1850 0.065*
H15C 0.0901 0.6745 −0.0690 0.065*
C16 0.62889 (16) 0.5001 (4) −0.24275 (14) 0.0279 (4)
C17 0.58739 (18) 0.3343 (4) −0.31796 (15) 0.0301 (4) 0.901 (4)
N1 0.52374 (18) 0.1616 (4) −0.29365 (15) 0.0308 (5) 0.901 (4)
H1N 0.524 (3) 0.047 (5) −0.334 (2) 0.046* 0.901 (4)
H2N 0.530 (3) 0.136 (6) −0.225 (2) 0.046* 0.901 (4)
C17′ 0.58739 (18) 0.3343 (4) −0.31796 (15) 0.0301 (4) 0.099 (4)
H17′ 0.5450 0.2160 −0.2992 0.036* 0.099 (4)
C18 0.61026 (19) 0.3482 (5) −0.42116 (16) 0.0349 (5)
H18 0.5830 0.2377 −0.4728 0.042*
C19 0.67180 (19) 0.5197 (5) −0.44896 (16) 0.0382 (6)
H19 0.6843 0.5279 −0.5201 0.046*
C20 0.71561 (19) 0.6804 (4) −0.37407 (18) 0.0372 (5)
H20 0.7588 0.7973 −0.3932 0.045*
C21 0.69556 (18) 0.6680 (4) −0.27111 (17) 0.0315 (5) 0.901 (4)
H21 0.7275 0.7751 −0.2188 0.038* 0.901 (4)
C21′ 0.69556 (18) 0.6680 (4) −0.27111 (17) 0.0315 (5) 0.099 (4)
N1′ 0.7329 (16) 0.843 (3) −0.2219 (13) 0.0308 (5) 0.099 (4)
H1N′ 0.7209 0.8389 −0.1538 0.046* 0.099 (4)
H2N′ 0.8119 0.8571 −0.2175 0.046* 0.099 (4)
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0318 (8) 0.0637 (13) 0.0419 (8) 0.0018 (9) 0.0144 (6) 0.0236 (8)
O2 0.0381 (7) 0.0293 (8) 0.0295 (6) 0.0003 (8) 0.0160 (5) 0.0015 (7)
O3 0.0452 (8) 0.0288 (8) 0.0258 (6) −0.0091 (8) 0.0060 (6) −0.0006 (7)
C1 0.0382 (12) 0.0304 (13) 0.0368 (10) 0.0021 (11) 0.0093 (9) −0.0045 (9)
C2 0.0356 (12) 0.0331 (14) 0.0491 (12) −0.0049 (10) 0.0075 (9) 0.0010 (10)
C3 0.0324 (11) 0.0388 (15) 0.0542 (13) 0.0006 (11) 0.0162 (9) 0.0129 (11)
C4 0.0310 (11) 0.0456 (15) 0.0331 (10) 0.0096 (11) 0.0154 (8) 0.0133 (10)
C5 0.0325 (10) 0.0298 (12) 0.0401 (10) 0.0067 (10) 0.0166 (8) 0.0112 (10)
C6 0.0311 (10) 0.0266 (11) 0.0314 (9) 0.0056 (10) 0.0130 (7) 0.0072 (9)
C7 0.0269 (9) 0.0251 (11) 0.0279 (8) 0.0011 (9) 0.0096 (7) 0.0014 (8)
C8 0.0277 (10) 0.0315 (12) 0.0282 (9) 0.0012 (9) 0.0094 (7) 0.0052 (8)
C9 0.0381 (11) 0.0335 (13) 0.0246 (8) 0.0022 (10) 0.0114 (7) −0.0011 (9)
C10 0.0314 (10) 0.0319 (12) 0.0205 (8) 0.0005 (11) 0.0029 (7) −0.0023 (9)
C11 0.0320 (10) 0.0204 (10) 0.0251 (8) 0.0004 (9) 0.0090 (7) −0.0003 (8)
C12 0.0389 (10) 0.0178 (10) 0.0287 (8) −0.0027 (10) 0.0110 (7) 0.0005 (9)
C13 0.0277 (9) 0.0281 (11) 0.0276 (8) 0.0002 (10) 0.0048 (7) −0.0002 (9)
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C14 0.0334 (11) 0.0383 (15) 0.0446 (12) 0.0063 (11) 0.0058 (9) 0.0133 (11)
C15 0.0393 (12) 0.0528 (17) 0.0417 (12) 0.0142 (12) 0.0161 (9) −0.0052 (11)
C16 0.0221 (8) 0.0335 (12) 0.0285 (8) 0.0047 (10) 0.0071 (7) 0.0024 (9)
C17 0.0266 (9) 0.0338 (12) 0.0314 (9) 0.0032 (10) 0.0103 (7) −0.0003 (9)
N1 0.0382 (11) 0.0292 (12) 0.0270 (9) −0.0012 (9) 0.0122 (7) −0.0032 (8)
C17′ 0.0266 (9) 0.0338 (12) 0.0314 (9) 0.0032 (10) 0.0103 (7) −0.0003 (9)
C18 0.0333 (10) 0.0435 (15) 0.0299 (9) 0.0041 (11) 0.0119 (8) −0.0012 (10)
C19 0.0331 (10) 0.0509 (17) 0.0332 (10) 0.0071 (11) 0.0134 (8) 0.0107 (11)
C20 0.0274 (10) 0.0412 (15) 0.0456 (12) 0.0013 (11) 0.0140 (8) 0.0125 (11)
C21 0.0225 (9) 0.0351 (13) 0.0371 (10) 0.0021 (9) 0.0075 (7) 0.0011 (9)
C21′ 0.0225 (9) 0.0351 (13) 0.0371 (10) 0.0021 (9) 0.0075 (7) 0.0011 (9)
N1′ 0.0382 (11) 0.0292 (12) 0.0270 (9) −0.0012 (9) 0.0122 (7) −0.0032 (8)
Geometric parameters (Å, º) 
O1—C5 1.440 (2) C9—H9B 0.9900
O1—C4 1.456 (2) C10—C14 1.496 (3)
O2—C12 1.342 (3) C11—C13 1.332 (3)
O2—C6 1.458 (2) C11—C12 1.478 (2)
O3—C12 1.211 (3) C13—C16 1.474 (2)
C1—C10 1.323 (4) C13—H13 0.9500
C1—C2 1.508 (3) C14—H14A 0.9800
C1—H1 0.9500 C14—H14B 0.9800
C2—C3 1.544 (3) C14—H14C 0.9800
C2—H2A 0.9900 C15—H15A 0.9800
C2—H2B 0.9900 C15—H15B 0.9800
C3—C4 1.510 (4) C15—H15C 0.9800
C3—H3A 0.9900 C16—C21 1.402 (3)
C3—H3B 0.9900 C16—C17 1.409 (3)
C4—C5 1.471 (3) C17—N1 1.384 (3)
C4—C15 1.492 (4) C17—C18 1.402 (3)
C5—C6 1.504 (3) N1—H1N 0.88 (3)
C5—H5 1.0000 N1—H2N 0.87 (3)
C6—C7 1.556 (2) C18—C19 1.381 (4)
C6—H6 1.0000 C18—H18 0.9500
C7—C11 1.506 (3) C19—C20 1.388 (4)
C7—C8 1.550 (3) C19—H19 0.9500
C7—H7 1.0000 C20—C21 1.385 (3)
C8—C9 1.541 (3) C20—H20 0.9500
C8—H8A 0.9900 C21—H21 0.9500
C8—H8B 0.9900 N1′—H1N′ 0.9100
C9—C10 1.509 (3) N1′—H2N′ 0.9100
C9—H9A 0.9900
C5—O1—C4 61.05 (13) C10—C9—H9B 108.8
C12—O2—C6 111.18 (13) C8—C9—H9B 108.8
C10—C1—C2 128.4 (2) H9A—C9—H9B 107.7
C10—C1—H1 115.8 C1—C10—C14 125.06 (19)
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C2—C1—H1 115.8 C1—C10—C9 121.1 (2)
C1—C2—C3 111.59 (19) C14—C10—C9 113.8 (2)
C1—C2—H2A 109.3 C13—C11—C12 119.54 (17)
C3—C2—H2A 109.3 C13—C11—C7 132.42 (16)
C1—C2—H2B 109.3 C12—C11—C7 108.03 (16)
C3—C2—H2B 109.3 O3—C12—O2 120.69 (17)
H2A—C2—H2B 108.0 O3—C12—C11 128.95 (19)
C4—C3—C2 110.5 (2) O2—C12—C11 110.35 (16)
C4—C3—H3A 109.6 C11—C13—C16 127.78 (17)
C2—C3—H3A 109.6 C11—C13—H13 116.1
C4—C3—H3B 109.6 C16—C13—H13 116.1
C2—C3—H3B 109.6 C10—C14—H14A 109.5
H3A—C3—H3B 108.1 C10—C14—H14B 109.5
O1—C4—C5 58.93 (13) H14A—C14—H14B 109.5
O1—C4—C15 112.9 (2) C10—C14—H14C 109.5
C5—C4—C15 122.7 (2) H14A—C14—H14C 109.5
O1—C4—C3 117.2 (2) H14B—C14—H14C 109.5
C5—C4—C3 115.6 (2) C4—C15—H15A 109.5
C15—C4—C3 116.50 (19) C4—C15—H15B 109.5
O1—C5—C4 60.02 (12) H15A—C15—H15B 109.5
O1—C5—C6 119.7 (2) C4—C15—H15C 109.5
C4—C5—C6 124.6 (2) H15A—C15—H15C 109.5
O1—C5—H5 114.0 H15B—C15—H15C 109.5
C4—C5—H5 114.0 C21—C16—C17 119.53 (17)
C6—C5—H5 114.0 C21—C16—C13 118.4 (2)
O2—C6—C5 108.06 (16) C17—C16—C13 122.1 (2)
O2—C6—C7 106.71 (15) N1—C17—C18 119.5 (2)
C5—C6—C7 111.96 (18) N1—C17—C16 122.18 (18)
O2—C6—H6 110.0 C18—C17—C16 118.4 (2)
C5—C6—H6 110.0 C17—N1—H1N 115 (2)
C7—C6—H6 110.0 C17—N1—H2N 117 (2)
C11—C7—C8 115.51 (17) H1N—N1—H2N 115 (3)
C11—C7—C6 102.31 (14) C19—C18—C17 121.1 (2)
C8—C7—C6 115.32 (17) C19—C18—H18 119.4
C11—C7—H7 107.7 C17—C18—H18 119.4
C8—C7—H7 107.7 C18—C19—C20 120.67 (19)
C6—C7—H7 107.7 C18—C19—H19 119.7
C9—C8—C7 112.77 (18) C20—C19—H19 119.7
C9—C8—H8A 109.0 C21—C20—C19 119.1 (2)
C7—C8—H8A 109.0 C21—C20—H20 120.4
C9—C8—H8B 109.0 C19—C20—H20 120.4
C7—C8—H8B 109.0 C20—C21—C16 121.1 (2)
H8A—C8—H8B 107.8 C20—C21—H21 119.4
C10—C9—C8 113.94 (16) C16—C21—H21 119.4
C10—C9—H9A 108.8 H1N′—N1′—H2N′ 109.5
C8—C9—H9A 108.8
C10—C1—C2—C3 −107.8 (3) C8—C9—C10—C1 −103.1 (2)
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C1—C2—C3—C4 49.0 (3) C8—C9—C10—C14 74.6 (2)
C5—O1—C4—C15 −115.5 (2) C8—C7—C11—C13 −43.4 (4)
C5—O1—C4—C3 104.9 (2) C6—C7—C11—C13 −169.5 (3)
C2—C3—C4—O1 −151.63 (19) C8—C7—C11—C12 135.47 (19)
C2—C3—C4—C5 −85.0 (2) C6—C7—C11—C12 9.4 (2)
C2—C3—C4—C15 70.2 (2) C6—O2—C12—O3 176.5 (2)
C4—O1—C5—C6 115.1 (3) C6—O2—C12—C11 −4.5 (3)
C15—C4—C5—O1 98.8 (2) C13—C11—C12—O3 −5.6 (4)
C3—C4—C5—O1 −107.7 (2) C7—C11—C12—O3 175.3 (2)
O1—C4—C5—C6 −107.3 (2) C13—C11—C12—O2 175.4 (2)
C15—C4—C5—C6 −8.5 (3) C7—C11—C12—O2 −3.6 (3)
C3—C4—C5—C6 145.1 (2) C12—C11—C13—C16 178.2 (2)
C12—O2—C6—C5 131.12 (19) C7—C11—C13—C16 −3.0 (4)
C12—O2—C6—C7 10.6 (3) C11—C13—C16—C21 127.5 (3)
O1—C5—C6—O2 44.4 (3) C11—C13—C16—C17 −52.3 (3)
C4—C5—C6—O2 116.6 (2) C21—C16—C17—N1 178.3 (2)
O1—C5—C6—C7 161.60 (18) C13—C16—C17—N1 −1.9 (3)
C4—C5—C6—C7 −126.2 (2) C21—C16—C17—C18 −2.7 (3)
O2—C6—C7—C11 −11.8 (2) C13—C16—C17—C18 177.11 (19)
C5—C6—C7—C11 −129.85 (19) N1—C17—C18—C19 179.0 (2)
O2—C6—C7—C8 −138.03 (19) C16—C17—C18—C19 −0.1 (3)
C5—C6—C7—C8 103.9 (2) C17—C18—C19—C20 1.8 (3)
C11—C7—C8—C9 146.42 (18) C18—C19—C20—C21 −0.8 (3)
C6—C7—C8—C9 −94.4 (2) C19—C20—C21—C16 −2.0 (3)
C7—C8—C9—C10 71.1 (2) C17—C16—C21—C20 3.8 (3)
C2—C1—C10—C14 −6.3 (4) C13—C16—C21—C20 −176.0 (2)
C2—C1—C10—C9 171.1 (2)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
C5—H5···O3i 1.00 2.59 3.268 (3) 125
C7—H7···O3i 1.00 2.57 3.226 (3) 123
C15—H15A···O1ii 0.98 2.40 3.223 (3) 141
Symmetry codes: (i) −x+1, y−1/2, −z; (ii) −x, y+1/2, −z.
